Indication
Levosalbutamol is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease.
Dosage & Administration
Levodil®1 & Levodil®2 tablets: Adults and adolescents above 12 years: 1-2 mg three times daily. Children (6 -11 years): 1 mg three times daily. Levodil® syrup: Adults: 5-10 ml three times daily. Children (6-11 years): 5 ml three times daily.
Precautions
Potentially serious hypokalemia may result from beta 2- agonist therapy. Levosalbutamol, like all other beta-adrenergic agonists, can produce a clinically significant cardiovascular effect in some patients, as measured by pulse rate, blood pressure and/or symptoms. Although such effects are uncommon after administration of Levosalbutamol at recommended doses, if they occur, the drug may need to be discontinued. Oral Levosalbutamol should be used with caution in patients with cardiovascular disorders, especially coronary insufficiency, cardiac arrhythmias or hypertension. Use in Pregnancy: Use of oral Levosalbutamol in a pregnant woman should be considered only if the expected benefit to the mother is greater than any possible risk to the foetus. Use in Lactation: It is not known whether Levosalbutamol is excreted in human milk. Caution should be exercised when oral levosalbutamol is administered to a nursing woman.
